Search

everythinglearnresearchcommunity

for

Search:↓

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.

Targeting CD169+ skin macrophages may help treat psoriasis.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Blocking IL-17a can improve age-related smell loss in mice.

Alopecia areata involves specific gene changes and immune pathways, offering new treatment targets.

Cholecystokinin may help reduce skin inflammation in psoriasis.

The hydrogel patch helps heal diabetic wounds by releasing a healing agent in response to harmful molecules and improving skin regeneration.

Epiduo® is an effective first-line acne treatment that reduces inflammation and combats antibiotic resistance.

Anti-EGFR therapy can cause skin issues, but FGF7 treatment might help.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Alopecia areata severity and treatment response are linked to specific cytokine levels.